[The results of a clinical trial of flurenizid in phthisiopulmonology practice].

Flurenizide, a new home drug preparation, endowed with antituberculosis activity, was administered to 20 patients with freshly detected pulmonary tuberculosis, in combination with etambutole or rifampycin in a daily dose of 0.6 g. After the above chemotherapy, closure of the cavities, diminution in size and consolidation of the foci as well as infiltrates, dispelling of the symptoms of intoxication, and discontinuance of bacteria discharge were observable in 70.

[The characteristics of the anatomicophysiological development and hormonal activity in adolescents with tuberculosis of the respiratory organs].

Parameters of physical development were evaluated using the main anthropometric tests (weight, height, chest circumference) as were those of hormonal activity (the level of somatotrophic hormone, immunoreactive insulin, the content of 17-keto-steroids) in adolescents with tuberculosis of respiratory organs. The above criteria enable one to judge of reactivity and compensatory potential of a specific process and the nature of residual alterations.